Olivier Civelli | Academic Influence

Olivier Civelli's AcademicInfluence.com Rankings

Olivier Civelli

Medical

#2548

World Rank

#2976

Historical Rank

Pharmacology

#276

World Rank

#324

Historical Rank

medical Degrees

Download Badge

Medical

Olivier Civelli's Degrees

PhD Pharmacology University of California, San Francisco

Why Is Olivier Civelli Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Olivier Civelli is a molecular biologist, a researcher in the field of neuropharmacology and an educator. He is the Eric L. and Lila D. Nelson Professor of Neuropharmacology at University of California, Irvine. He is also a Professor in the Department of Developmental and Cell Biology at University of California, Irvine. He is most known for his work in advancing understanding of neurotransmission and his impact on drug discovery.

(See a Problem?)

Olivier Civelli's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine (1991) (2003)
Orphanin FQ: A Neuropeptide That Activates an Opioidlike G Protein-Coupled Receptor (1995) (1783)
Cloning and expression of a rat D2 dopamine receptor cDNA (1988) (1089)
Multiple dopamine D4 receptor variants in the human population (1992) (990)
Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor. (1992) (652)
Molecular diversity of the dopamine receptors. (1993) (641)
Molecular characterization of the melanin-concentrating-hormone receptor (1999) (512)
Cloning and expression of human and rat Dt dopamine receptors (1990) (491)
Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat brain and pituitary: an in situ hybridization- receptor autoradiographic analysis (1990) (481)
Neuropeptide S A Neuropeptide Promoting Arousal and Anxiolytic-like Effects (2004) (472)
Cloning, functional expression, and mRNA tissue distribution of the rat 5-hydroxytryptamine1A receptor gene. (1990) (447)
The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. (1989) (438)
Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat (1999) (387)
Orphanin FQ is a functional anti-opioid peptide (1996) (366)
Expression of the melanin‐concentrating hormone (MCH) receptor mRNA in the rat brain (2001) (356)
Opioid receptor‐like (ORL1) receptor distribution in the rat central nervous system: Comparison of ORL1 receptor mRNA expression with 125I‐[14Tyr]‐orphanin FQ binding (1999) (350)
Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. (1997) (341)
Differential activation of spinal cord dynorphin and enkephalin neurons during hyperalgesia: evidence using cDNA hybridization (1988) (278)
PCR detection of the TaqA RFLP at the DRD2 locus. (1993) (276)
Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S‐expressing neurons in the rat brain (2007) (258)
A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques (1991) (253)
Comparison of the distributions of D1 and D2 dopamine receptor mRNAs in rat brain. (1991) (251)
Distribution of D2 dopamine receptor mRNA in rat brain. (1989) (247)
Primary structure and tissue distribution of the orphanin FQ precursor. (1996) (244)
Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice. (1999) (243)
Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction (1999) (229)
Differential coupling of dopaminergic D2 receptors expressed in different cell types. Stimulation of phosphatidylinositol 4,5-bisphosphate hydrolysis in LtK- fibroblasts, hyperpolarization, and cytosolic-free Ca2+ concentration decrease in GH4C1 cells. (1990) (226)
Pharmacological Characterization of Human and Murine Neuropeptide S Receptor Variants (2005) (214)
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors (2021) (212)
Multiple human D5 dopamine receptor genes: a functional receptor and two pseudogenes. (1991) (205)
Structure-Activity Relationship Studies on the Novel Neuropeptide Orphanin FQ* (1996) (190)
Detection and characterization of additional DNA polymorphisms in the dopamine D2 receptor gene. (1991) (187)
Distribution of D5 dopamine receptor mRNA in rat brain (1992) (187)
Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist. (2000) (184)
Modulation of Voltage-Gated Calcium Channels by Orphanin FQ in Freshly Dissociated Hippocampal Neurons (1996) (181)
Molecular biology of the dopamine receptors. (1991) (172)
Dopamine Receptor Gene Expression in the Human Medial Temporal Lobe (1994) (164)
Site-directed mutagenesis of the human dopamine D2 receptor. (1992) (157)
The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion (1996) (153)
G protein-coupled receptor deorphanizations. (2013) (151)
Coupling of a cloned rat dopamine-D2 receptor to inhibition of adenylyl cyclase and prolactin secretion. (1990) (151)
The melanin-concentrating hormone system modulates cocaine reward (2009) (133)
The D4 dopamine receptor (DRD4) maps to distal 11p close to HRAS. (1992) (131)
Novel neurotransmitters as natural ligands of orphan G-protein-coupled receptors (2001) (130)
Molecular cloning and expression of the rat β1-adrenergic receptor gene. (1990) (128)
Epinephrine and Norepinephrine Act as Potent Agonists at the Recombinant Human Dopamine D4 Receptor (1997) (127)
No linkage between D2 dopamine receptor gene region and schizophrenia. (1991) (123)
Adenosine A1 Receptor-mediated Modulation of Dopamine D1 Receptors in Stably Cotransfected Fibroblast Cells* (1998) (117)
Direct sequencing of the dopamine D2 receptor (DRD2) in schizophrenics reveals three polymorphisms but no structural change in the receptor. (1991) (117)
Orphan GPCR research (2008) (112)
The Dopamine D2 Receptor (1992) (111)
GPCR deorphanizations: the novel, the known and the unexpected transmitters. (2005) (110)
Cloning and expression of human and rat D1 dopamine receptors. (1990) (109)
GPR39 receptor expression in the mouse brain (2006) (107)
Lack of effect of chronic dopamine receptor blockade on D2 dopamine receptor mRNA level (1990) (96)
Melanin-concentrating Hormone Receptor: An Orphan Receptor Fits the Key (2000) (93)
Dopaminergic inhibition of DNA synthesis in pituitary tumor cells is associated with phosphotyrosine phosphatase activity. (1992) (89)
Gait Disorders in Parkinsonian Monkeys with Pedunculopontine Nucleus Lesions: A Tale of Two Systems (2013) (84)
Differential Sensitivity of the Short and Long Human Dopamine D2 Receptor Subtypes to Protein Kinase C (1992) (82)
Moving from the Orphanin FQ Receptor to an Opioid Receptor Using Four Point Mutations* (1996) (79)
A Novel Analgesic Isolated from a Traditional Chinese Medicine (2014) (79)
Purification, cloning, and tissue distribution of a 23-kDa rat protein isolated by morphine affinity chromatography. (1990) (78)
Structure and linkage of the D2 dopamine receptor and neural cell adhesion molecule genes on human chromosome 11q23. (1992) (78)
Orphan GPCRs and their ligands. (2006) (77)
Gilles de la Tourette syndrome is not linked to D2-dopamine receptor. (1990) (71)
Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ (1996) (71)
Functional characterization of a rat dopamine D-2 receptor cDNA expressed in a mammalian cell line. (1989) (71)
A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques (1992) (71)
Recent Updates on the Melanin-Concentrating Hormone (MCH) and Its Receptor System: Lessons from MCH1R Antagonists (2010) (68)
Urotensin II Modulates Rapid Eye Movement Sleep through Activation of Brainstem Cholinergic Neurons (2005) (68)
The orphanin FQ/nociceptin gene: structure, tissue distribution of expression and functional implications obtained from knockout mice (2000) (67)
A human D1 dopamine receptor gene is located on chromosome 5 at q35.1 and identifies an EcoRI RFLP. (1990) (66)
A Drosophila adenosine receptor activates cAMP and calcium signaling. (2007) (65)
Endogenous Orphanin FQ/Nociceptin Is Involved in the Development of Morphine Tolerance (2006) (65)
The cloned dopamine D2 receptor reveals different densities for dopamine receptor antagonist ligands. Implications for human brain positron emission tomography. (1992) (64)
The urotensin II receptor is expressed in the cholinergic mesopontine tegmentum of the rat (2001) (63)
Regulation of responsiveness at D2 dopamine receptors by receptor desensitization and adenylyl cyclase sensitization. (1991) (61)
Functional genomics: the search for novel neurotransmitters and neuropeptides (1998) (59)
Interaction of [3H]orphanin FQ and 125I-Tyr14-orphanin FQ with the orphanin FQ receptor: kinetics and modulation by cations and guanine nucleotides. (1997) (58)
The melanin-concentrating hormone (MCH) system in an animal model of depression-like behavior (2012) (58)
Cholera toxin-sensitive 3',5'-cyclic adenosine monophosphate and calcium signals of the human dopamine-D1 receptor: selective potentiation by protein kinase A. (1992) (57)
Orphan G protein‐coupled receptors: targets for new therapeutic interventions (2004) (57)
Reverse physiology: discovery of the novel neuropeptide, orphanin FQ/nociceptin. (1998) (55)
The translational repression of globin mRNA in free cytoplasmic ribonucleoprotein complexes. (2005) (53)
Orphanin FQ/nociceptin interacts with the basolateral amygdala noradrenergic system in memory consolidation. (2007) (52)
The orphanin FQ/nociceptin (OFQ/N) system. (2008) (50)
Exclusion of close linkage of Tourette's syndrome to D1 dopamine receptor. (1993) (50)
Orphan GPCRs and Neuromodulation (2012) (47)
Increased spinal cord dynorphin mRNA during peripheral inflammation. (1986) (46)
The carboxyl terminus of the prolactin-releasing peptide receptor interacts with PDZ domain proteins involved in alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor clustering. (2001) (45)
Differential expression of the thyrostimulin subunits, glycoprotein α2 and β5 in the rat pituitary (2006) (45)
The orphanin FQ/nociceptin knockout mouse: A behavioral model for stress responses (2002) (45)
A study of the rat neuropeptide B/neuropeptide W system using in situ techniques (2006) (44)
Endogenous melanin-concentrating hormone receptor SLC-1 in human melanoma SK-MEL-37 cells. (2001) (44)
The Antinociceptive Properties of the Corydalis yanhusuo Extract (2016) (44)
Prolactin-releasing peptide (PrRP) promotes awakening and suppresses absence seizures (2002) (43)
DIFFERENTIAL COUPLING OF DOPAMINERGIC D2 RECEPTORS EXPRESSED INDIFFERENT CELL TYPES (1990) (43)
Cancer metastasis-suppressing peptide metastin upregulates excitatory synaptic transmission in hippocampal dentate granule cells. (2005) (43)
Neurochemical properties of the prolactin releasing peptide (PrRP) receptor expressing neurons: evidence for a role of PrRP as a regulator of stress and nociception (2002) (42)
Genetic linkage is excluded for the D2-dopamine receptor lambda HD2G1 and flanking loci on chromosome 11q22-q23 in Tourette syndrome. (1990) (42)
Neuropeptide S: a new player in the modulation of arousal and anxiety. (2005) (41)
Correlation of specific coding sequences with specific proteins associated in untranslated cytoplasmic messenger ribonucleoprotein complexes of duck er (1977) (41)
Evidence that stimulatory dopamine receptors may be involved in the regulation of prolactin secretion. (1994) (40)
Fusion of diphtheria toxin and urotensin II produces a neurotoxin selective for cholinergic neurons in the rat mesopontine tegmentum (2007) (40)
Orphan G protein-coupled receptors and obesity. (2004) (39)
The somatostatin receptors SSTR1 and SSTR2 are coupled to inhibition of adenylyl cyclase in Chinese hamster ovary cells via pertussis toxin-sensitive pathways. (1994) (39)
Lack of association between schizophrenia and alleles of the dopamine D1, D2, D3 and D4 receptor loci1 (1993) (39)
Identification and characterization of the translationally repressed cytoplasmic globin messenger-ribonucleoprotein particles from duck erythroblasts. (2005) (37)
Histamine inhibits the melanin‐concentrating hormone system: implications for sleep and arousal (2014) (36)
Distribution of D2 dopamine receptor mRNA in the primate brain (1991) (36)
Chromosomal localization of three human D5 dopamine receptor genes. (1992) (36)
Inactivation of the melanin concentrating hormone system impairs maternal behavior (2016) (34)
Creating a functional opioid alkaloid binding site in the orphanin FQ receptor through site-directed mutagenesis. (1998) (34)
Salusin β is a surrogate ligand of the mas-like G protein-coupled receptor MrgA1 (2006) (33)
Proadrenomedullin N-terminal peptide and cortistatin activation of MrgX2 receptor is based on a common structural motif. (2005) (33)
Dopamine receptor diversity: molecular and pharmacological perspectives. (1997) (32)
A Methionine-Induced Animal Model of Schizophrenia: Face and Predictive Validity (2015) (32)
Orphan receptors, novel neuropeptides and reverse pharmaceutical research (1999) (31)
High-throughput real-time monitoring of Gs-coupled receptor activation in intact cells using cyclic nucleotide-gated channels. (2003) (31)
Transcriptional and post-transcriptional regulation in duck erythroblasts. (1982) (31)
Development and characterization of antibodies directed against the mouse D4 dopamine receptor (1998) (28)
Linkage analysis of the D1 dopamine receptor gene and manic depression in six families. (1992) (27)
Messenger RNA for the 73,000-dalton poly(A)-binding protein occurs as translationally repressed mRNP in duck reticulocytes. (1983) (26)
Anatomical characterization of bombesin receptor subtype‐3 mRNA expression in the rodent central nervous system (2013) (26)
Molecular attributes of dopamine receptors: new potential for antipsychotic drug development. (1996) (25)
D2 dopamine receptor gene not linked to manic- depression in three families (1990) (25)
Urotensin II acts as a modulator of mesopontine cholinergic neurons (2005) (25)
G-protein-coupled receptors: the new dopamine receptor subtypes (1992) (25)
Biochemical roles of the oligosaccharide chains in thyrostimulin, a heterodimeric hormone of glycoprotein hormone subunits alpha2 (GPA2) and beta5 (GPB5) (2008) (24)
Prenatal one-carbon metabolism dysregulation programs schizophrenia-like deficits (2018) (23)
Orphan receptors and their natural ligands. (1997) (23)
MCH receptors/gene structure-in vivo expression (2009) (23)
Differential expression of the thyrostimulin subunits, glycoprotein alpha2 and beta5 in the rat pituitary. (2006) (22)
BmK-YA, an Enkephalin-Like Peptide in Scorpion Venom (2012) (22)
The Melanin-Concentrating Hormone (MCH) System Modulates Behaviors Associated with Psychiatric Disorders (2011) (22)
Amide Alkaloids from Scopolia tangutica (2014) (21)
The opioid peptide nociceptin/orphanin FQ mediates prostaglandin E2‐induced allodynia, tactile pain associated with nerve injury (2006) (21)
Melanin concentrating hormone modulates oxytocin-mediated marble burying (2018) (21)
Pharmacological characterization of a selective agonist for bombesin receptor subtype-3. (2009) (20)
Study on the Activation of the Opioid Receptors by a Set of Morphine Derivatives in a Well-Defined Assay System (2012) (20)
Identification of neuropeptide receptors expressed by melanin‐concentrating hormone neurons (2014) (19)
The distribution of dopamine D2 receptor heteronuclear RNA (hnRNA) in the rat brain (1993) (18)
Molecular cloning and expression of the rat beta 1-adrenergic receptor gene. (1990) (18)
The pharmacological properties of a novel MCH1 receptor antagonist isolated from combinatorial libraries. (2009) (16)
MCH and apomorphine in combination enhance action potential firing of nucleus accumbens shell neurons in vitro (2013) (16)
Anxiolytic Effects of the MCH1R Antagonist TPI 1361-17 (2010) (16)
The effects of nigrostriatal 6-hydroxydopamine lesions on dopamine D2 receptor mRNA and opioid systems. (1990) (15)
G-protein-coupled receptors: The new dopamine receptor subtypes (1992) (14)
A TaqI RFLP at the DRD1 locus. (1991) (14)
Dopaminergic activity measured in D1- and D2-transfected fibroblasts by silicon-microphysiometry. (1993) (14)
The role of Olfaction in MCH-regulated spontaneous maternal responses (2019) (14)
Patterns of cilia gene dysregulations in major psychiatric disorders (2021) (13)
Salusin beta is a surrogate ligand of the mas-like G protein-coupled receptor MrgA1. (2006) (12)
CHAPTER 1 – Generation of Diversity of Opioid Peptides (1985) (12)
Molecular biology of the dopamine D2 receptor. (1991) (12)
Melanin Concentrating Hormone Signaling Deficits in Schizophrenia: Association With Memory and Social Impairments and Abnormal Sensorimotor Gating (2019) (12)
Mice lacking Melanin Concentrating Hormone 1 receptor are resistant to seizures (2010) (11)
Messenger ribonucleoprotein complexes in avian erythroblasts: Carriers of post-transcriptional regulation? (1979) (11)
Molecular characterization of dopamine receptors. (1990) (10)
A Natural Product with High Affinity to Sigma and 5-HT7 Receptors as Novel Therapeutic Drug for Negative and Cognitive Symptoms of Schizophrenia (2019) (10)
Novel neuropeptides as ligands of orphan G protein-coupled receptors. (2011) (9)
Potential role of mRNP proteins in cytoplasmic control of gene expression in duck erythroblasts (1981) (9)
Interaction of Antipsychotic Drugs with Dopamine Receptor Subtypes (1996) (9)
Dopamine receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database (2019) (9)
Functional characterization of the human dopamine D4.2 receptor using vaccinia virus as an expression system. (1995) (8)
Site-directed mutagenesis of the human dopamine D 2 receptor (2003) (8)
Synthesis of albumin and malic enzyme in wheat-germ lysates and Xenopus laevis oocytes programmed with chicken-liver messenger RNA. (1979) (8)
Hydroxycinnamic acid amides from Scopolia tangutica inhibit the activity of M1 muscarinic acetylcholine receptor in vitro. (2016) (8)
Discovery of N-methyltetrahydroprotoberberines with κ-opioid receptor agonists-opioid receptor agonist activities from corydalis yanhusuo W. T. Wang by using two-dimensional liquid chromatography. (2014) (8)
Opioid receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database (2019) (8)
Association of Myoinositol Transporters with Schizophrenia and Bipolar Disorder: Evidence from Human and Animal Studies (2019) (8)
Orphan G protein-coupled receptors and novel neuropeptides. Introduction. (2008) (7)
Oxytocin-MCH circuit regulates monosynaptic inputs to MCH neurons and modulates social recognition memory (2020) (7)
TWENTY QUESTIONS: THE STATE OF GPCR RESEARCH IN 2004 (2004) (7)
Acute Homeostatic Responses to Increased Fat Consumption in MCH1R Knockout Mice (2010) (7)
Regulation of expression of opioid peptide genes (1984) (7)
Transcriptome Profiling of Dysregulated GPCRs Reveals Overlapping Patterns across Psychiatric Disorders and Age-Disease Interactions (2021) (7)
Disruption of the melanin-concentrating hormone receptor 1 (MCH1R) affects thyroid function. (2012) (7)
Lack of effect of chromic dopamine receptor blockade on D2 dopamine receptor mRNA levels (1990) (6)
Orphan neuropeptides Novel neuropeptides modulating sleep or feeding (2006) (6)
An Orphan Receptor Adopted by a Family of Transmitters (2005) (6)
Different Structural Requirements for Melanin‐Concentrating Hormone (MCH) Interacting with Rat MCH‐R1 (SLC‐1) and Mouse B16 Cell MCH‐R (2003) (6)
Receptor‐specific crosstalk between prostanoid E receptor 3 and bombesin receptor subtype 3 (2018) (5)
Design, synthesis and SAR analysis of novel potent and selective small molecule antagonists of NPBWR1 (GPR7). (2012) (5)
The neuroreceptors: one key for many locks. (1995) (5)
Replica filter screening technique to detect transfected cells expressing beta 2-adrenergic receptor. (1989) (5)
The diversity of the dopamine receptors. (1992) (5)
Distribution of mRNA encoding a novel opioid receptor in mouse brain (1994) (5)
3 – Biosynthesis of ACTH and Related Peptides (1987) (5)
Linkage map of eight human chromosome 11q markers, including DRD2, spanning 60 cM. (1992) (5)
The Analgesic Properties of Corydalis yanhusuo (2021) (4)
Orphan receptors and the concept of reverse physiology: discovery of the novel neuropeptide orphanin FQ/nociceptin. (1999) (4)
Relaxin-3 , INSL 5 , and Their Receptors (4)
Cloning of Dopamine Receptors: Homology Approach (1992) (3)
Optimization and Characterization of an Antagonist for G-Protein Coupled Receptor 7 (GPR7) (2011) (3)
Nucleotide and deduced amino acid sequence of bovine adrenal medulla chromogranin B (secretogranin I) (1992) (3)
The D2 receptor: an inhibitory receptor which can trigger stimulatory responses (1992) (3)
G-protein-coupled receptor deorphanizations. (2013) (3)
Orphan GPCRs in the regulation of sleep and circadian rhythm (2005) (3)
Correlation of specific coding sequences with specific proteins associated in untranslated cytoplasmic messenger ribonucleoprotein complexes of duck erythroblasts. (1977) (3)
Messenger RNA for cataractous lens proteins are also present on normal lens polyribosomes. (1980) (3)
Opioid receptors in GtoPdb v.2021.3 (2021) (2)
The Extract of Corydalis yanhusuo Prevents Morphine Tolerance and Dependence (2021) (2)
The History of N/OFQ and the NOP Receptor. (2019) (2)
De-Orphanizing GPCRs and Drug Development (2005) (2)
The Dopamine Receptors (2010) (2)
Orphan Receptors: Promising Targets for Drug Discovery (2005) (1)
Functional genomics and the discovery of new drug targets. (1999) (1)
Protective effects of neuropeptide S against MK-801-induced psychotic-like behavior and neuropathological changes (2006) (1)
The next frontier in the molecular biology of the opioid system (1987) (1)
Dopamine D4 receptors: Molecular biology and pharmacology (2002) (1)
Human dopamine receptor d4 and its uses (1991) (1)
Cloning of a Rat D2-Dopamine Receptor cDNA (1989) (1)
Linkage studies of two new genes of neuropsychiatric interest (1991) (1)
P.2.b.009 The melanin-concentrating hormone system and emotional-like behaviour (2011) (1)
Edward Herbert (1926–1987) (1987) (1)
Reviewers 2011 (2012) (0)
Dopaminergic control of cell growth in GH4CIZ-R7 cell line: Possible involvement of a stimulation of phospho-tyrosine phosphatase (PTP) activity (1992) (0)
Table 1, Published GPR7 antagonist (2010) (0)
Figure 1, LC-MS results for probe ML250 (2013) (0)
Neuropeptide S receptor in GtoPdb v.2021.3 (2021) (0)
Three technical approaches for cloning opioid receptors. (1988) (0)
Dopamine Receptors: Molecular Pharmacology (2001) (0)
S.13.05 The impact of the search for novel neuropeptides on psychopharmacology (1997) (0)
Effects of urotensin-II in the regulation of REM sleep (2003) (0)
Differential signalling at various D2 receptors expressed in different cell types (1990) (0)
The molecular cloning of the dopamine receptors and the discovery of the dopamine D4 receptor (1994) (0)
for dopamine receptor antagonist ligands. Implications for human brain positron emission tomography (1992) (0)
S.09.01: The dopamine receptors and schizophrenia therapy (1996) (0)
Table 2, Overview of PubChem assays for GPR7 antagonist project (2010) (0)
The orphan GPCRs: Targets of the future neuropsychopharmacological drugs (2002) (0)
Table 6, Targets that exhibited ≥50% in Ricerca screening (2010) (0)
Human dopamine D 4 receptor and uses thereof (1991) (0)
l-Methionine effects on proliferation and cell death of human neuroplastoma SH-SY5Y and mouse hippocampus (2019) (0)
Review for "Ciliary melanin-concentrating hormone receptor 1 (MCHR1) is widely distributed in the murine CNS in a sex-independent manner" (2020) (0)
Identification and Pharmacological characterization of Bombesin receptor subtype‐3 selective agonist (2007) (0)
A receptor-specific crosstalk between the prostanoid 3 and the Bombesin sub-type 3 receptors (2018) (0)
Neuropeptide S receptor (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database (2019) (0)
The central effect of MCH system studied using a specific MCH 1R antagonist isolated from combinatorial libraries (2006) (0)
Dopamine D1 and D5 receptors: molecular cloning and pharmacological characteristics (1994) (0)
GPCRs, twenty five years later (2010) (0)
Comprar Orphan G Protein-Coupled Receptors and Novel Neuropeptides | Civelli, Olivier | 9783540783503 | Springer (2008) (0)
Study on the Activation of the Opioid Receptors by a Set of Morphine Derivatives in a Well-Defined Assay System (2011) (0)
EXPRESSION OF THE OPIOID GENES (1983) (0)
Figure 2, Stability of probe ML250 in PBS (2010) (0)
"Of particular iMere&' - in the opinion of neurobiologists. (1992) (0)
Table 4, SAR Table (2010) (0)
Orphan Neuropeptides and the Regulation of Food Intake (2008) (0)
Transcriptome Profiling of Dysregulated GPCRs in Psychiatric Disorders Reveals Overlap and Age-Disease Interactions (2021) (0)
Figure 4, GPR7 antagonist HTS overview (2010) (0)
Sequence and expression of the rat prodynorphin gene ( dynorphin / a-neoendorphin / genomic DNA / gene evolution / gene expression ) (2003) (0)
Effects of neuropeptide S in the regulation of sleep-wake cycle (2004) (0)

This paper list is powered by the following services:

Other Resources About Olivier Civelli

en.wikipedia.org

What Schools Are Affiliated With Olivier Civelli?

Olivier Civelli is affiliated with the following schools:

Image Attributions

Image Source for Olivier Civelli